Background Chemotherapy-induced toxicities lead to therapy dose reduction or delay,
affecting patient outcomes. This systematic review and meta-analysis evaluated the impact of …

Abstract Treatment for immune thrombocytopenia (ITP) in pregnancy is hampered by the
lack of fetal safety evidence of maternally‐administered medications. The Pregnancy …

Background Clinical practice guidelines recommend the use of bone-targeting agents for
preventing skeletal-related events (SREs) among patients with bone metastases from solid …

Introduction The experiences of patients with mild‐to‐moderate haemophilia differ from
those of patients with severe haemophilia or those without a bleeding disorder and include a …

Introduction Optimizing hemophilia care remains challenging in developing countries.
Burden-of-disease studies are important to develop strategies for improving hemophilia care. Aim …

Background Knowledge about thrombocytopenia among patients with solid tumors is scarce.
We examined the risk of thrombocytopenia among patients with solid tumors and its …

Background Sexual health plays a primary role in quality of life (QoL) for many people,
including those with hemophilia; however, there is little information available about sexual …

Purpose Glanzmann’s thrombasthenia (GT) is a rare bleeding disorder caused by a mutation
in the αIIbβ3 integrin essential for optimal platelet function and hemostasis. The aim of this …

Background Posterior fossa decompression (PFD) has been widely accepted for the surgical
treatment for Chiari malformation type I (CM1). However, inadequate decompression …

Purpose Congenital factor VII (FVII) deficiency is a rare bleeding disorder of variable phenotype
with predominantly mucocutaneous bleeding. The aim of this study was to identify the …